271 related articles for article (PubMed ID: 3893316)
1. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.
Fuchs PC; Jones RN; Barry AL; Thornsberry C
Antimicrob Agents Chemother; 1985 May; 27(5):679-82. PubMed ID: 3893316
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics.
Kessler RE; Bies M; Buck RE; Chisholm DR; Pursiano TA; Tsai YH; Misiek M; Price KE; Leitner F
Antimicrob Agents Chemother; 1985 Feb; 27(2):207-16. PubMed ID: 3885849
[TBL] [Abstract][Full Text] [Related]
3. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
4. The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin.
Neu HC; Chin NX; Jules K; Labthavikul P
J Antimicrob Chemother; 1986 Apr; 17(4):441-52. PubMed ID: 3486862
[TBL] [Abstract][Full Text] [Related]
5. In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.
Vuye A; Pijck J
Antimicrob Agents Chemother; 1985 Apr; 27(4):574-7. PubMed ID: 3859244
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of BMY-28142 in comparison with those of other beta-lactam antimicrobial agents.
Tsuji A; Maniatis A; Bertram MA; Young LS
Antimicrob Agents Chemother; 1985 Apr; 27(4):515-9. PubMed ID: 3839120
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activity of first, second and third generation cephalosporins.
Forsgren A
Acta Pathol Microbiol Scand B; 1981 Aug; 89(4):221-5. PubMed ID: 6274143
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporin.
Jones RN; Erwin ME
Antimicrob Agents Chemother; 1992 Jan; 36(1):233-8. PubMed ID: 1590695
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
[TBL] [Abstract][Full Text] [Related]
10. Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
Martínez-Beltrán J; Cantón R; Liñares J; García de Lomas J; Gimeno C; Tubau F; Baquero F
Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):244-52. PubMed ID: 7614970
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of BMY-28142, a new cephalosporin.
Norden CW; Neiderriter K
Chemotherapy; 1987; 33(1):15-7. PubMed ID: 3103990
[TBL] [Abstract][Full Text] [Related]
12. Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels.
Fung-Tomc J; Dougherty TJ; DeOrio FJ; Simich-Jacobson V; Kessler RE
Antimicrob Agents Chemother; 1989 Apr; 33(4):498-502. PubMed ID: 2499250
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems.
Jones RN; Erwin ME; Barrett MS; Johnson DM; Briggs BM
Diagn Microbiol Infect Dis; 1991; 14(4):301-9. PubMed ID: 1889181
[TBL] [Abstract][Full Text] [Related]
14. Cefquinome (HR 111V). In vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals.
Murphy SP; Erwin ME; Jones RN
Diagn Microbiol Infect Dis; 1994 Sep; 20(1):49-55. PubMed ID: 7867299
[TBL] [Abstract][Full Text] [Related]
15. Affinity of cephalosporins for beta-lactamases as a factor in antibacterial efficacy.
Phelps DJ; Carlton DD; Farrell CA; Kessler RE
Antimicrob Agents Chemother; 1986 May; 29(5):845-8. PubMed ID: 3524432
[TBL] [Abstract][Full Text] [Related]
16. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
van Klingeren B
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171
[TBL] [Abstract][Full Text] [Related]
17. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Phillips I; Warren C; Shannon K; King A; Hanslo D
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
[TBL] [Abstract][Full Text] [Related]
18. In vitro antimicrobial activity of RU-59863, a C-7 catechol substituted cephalosporin.
Erwin ME; Varnam D; Jones RN
Diagn Microbiol Infect Dis; 1997 Jun; 28(2):93-100. PubMed ID: 9239501
[TBL] [Abstract][Full Text] [Related]
19. HR 810 and BMY-28142, two new cephalosporins with broad-spectrum activity: an in-vitro comparison with other beta-lactam antibiotics.
Clarke AM; Zemcov SJ; Wright JM
J Antimicrob Chemother; 1985 Mar; 15(3):305-10. PubMed ID: 3838981
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of BMY-28142, a novel broad-spectrum cephalosporin.
Tomatsu K; Ando S; Masuyoshi S; Hirano M; Miyaki T; Kawaguchi H
J Antibiot (Tokyo); 1986 Nov; 39(11):1584-91. PubMed ID: 3539901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
